Genotoxicity test battery - An assessment of its utility in early drug development.

Abstract excerpt

Formal requirements for genotoxicity testing of drug candidates to support clinical entry have been in place since the issue of initial regulatory guidance over 25 years ago and subsequent update a decade ago. An evaluation of such testing, supporting first clinical entry of 108 small molecule drug candidates over the last decade, showed that the most common approach (75 % of tested compounds) was for a Good...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinogens
• Share to Drug Development
• Share to Drugs, Investigational